Menu
Company Status
All three antimicrobial compounds are currently in hit-to-lead stage preclinical development. It is expected that the first AQNO compound could be ready for market introduction by 2029 – 2030.
Company Status
All three antimicrobial compounds are currently in hit-to-lead stage preclinical development. It is expected that the first AQNO compound could be ready for market introduction by 2029 – 2030.